Marchetti B, Fortier M A, Poyet P, Folléa N, Pelletier G, Labrie F
Medical Research Council Group in Molecular Endocrinology, Laval University Medical Centre, Quebec, Canada.
Endocrinology. 1990 Jan;126(1):565-74. doi: 10.1210/endo-126-1-565.
To investigate a possible role of catecholamines in mammary gland growth and differentiation, we have studied the characteristics of a specific beta-adrenergic receptor population during the different reproductive phases of the rat mammary gland, namely pregnancy and lactation. The functional response to mammary beta-adrenergic receptor stimulation was assessed by measurement of adenylate cyclase activity during the same physiological states of the gland [125I]Cyanopindolol (CYP) binds specifically to membranes prepared from lactating mammary glands. Scatchard analysis of the binding data shows the presence of a single class of high affinity sites, with an apparent Kd value of 25.0 +/- 0.4 pM and a binding capacity of 32.5 +/- 1.2 fmol/mg protein in lactating mammary glands at random stages of lactation. The order of potency of a series of agonists to compete for [125I]CYP binding is consistent with the interactions with a beta 2-subtype receptor. The binding of [125I]CYP to mammary glands also shows a marked stereoselectivity; the (-)isomers of isoproterenol and propranolol are more potent than their respective enantiomers. The radioautographic localization of [125I]CYP reveals the presence of specific beta-adrenergic receptors in the epithelial cells, alveoles, ducts, as well as adipocytes. [125I]CYP binding shows a 2- to 3-fold increase during pregnancy. Such a result correlates with parallel increases in stimulation of adenylate cyclase activity, the cytosolic progesterone receptor concentration, as well as plasma 17 beta-estradiol and progesterone levels. At parturition, a sharp decline in beta-adrenergic receptor concentration is observed, a finding concomitant with a drop in progesterone receptor levels as well as plasma estradiol and progesterone concentrations. During midlactation, beta-adrenergic receptors reach their maximal levels. The presence of specific beta-adrenergic receptors functionally coupled to the adenylate cyclase system and the marked changes in receptor capacity and distribution measured during the different physiological states of the mammary gland suggest that the mammary beta-adrenergic receptors are highly sensitive to changes in the hormonal milieu and provide a mechanism for a direct catecholaminergic influence on mammary gland growth and differentiation.
为了研究儿茶酚胺在乳腺生长和分化中可能发挥的作用,我们研究了大鼠乳腺不同生殖阶段(即妊娠和泌乳期)特定β - 肾上腺素能受体群体的特征。通过在乳腺相同生理状态下测量腺苷酸环化酶活性来评估对乳腺β - 肾上腺素能受体刺激的功能反应。[125I]氰胍心安(CYP)特异性结合于泌乳期乳腺制备的膜。对结合数据的Scatchard分析表明存在一类单一的高亲和力位点,在泌乳期随机阶段的泌乳期乳腺中,其表观解离常数(Kd)值为25.0±0.4 pM,结合容量为32.5±1.2 fmol/mg蛋白质。一系列激动剂竞争[125I]CYP结合的效力顺序与与β2 - 亚型受体的相互作用一致。[125I]CYP与乳腺的结合也表现出明显的立体选择性;异丙肾上腺素和普萘洛尔的(-)异构体比它们各自的对映体更有效。[125I]CYP的放射自显影定位揭示了上皮细胞、腺泡、导管以及脂肪细胞中存在特异性β - 肾上腺素能受体。[125I]CYP结合在妊娠期间增加2至3倍。这一结果与腺苷酸环化酶活性刺激、胞质孕酮受体浓度以及血浆17β - 雌二醇和孕酮水平的平行增加相关。在分娩时,观察到β - 肾上腺素能受体浓度急剧下降,这一发现与孕酮受体水平以及血浆雌二醇和孕酮浓度的下降同时出现。在泌乳中期,β - 肾上腺素能受体达到其最高水平。在乳腺不同生理状态下测量到的与腺苷酸环化酶系统功能偶联的特异性β - 肾上腺素能受体的存在以及受体容量和分布的显著变化表明,乳腺β - 肾上腺素能受体对激素环境的变化高度敏感,并为儿茶酚胺能对乳腺生长和分化的直接影响提供了一种机制。